Nancy Thornberry Denali Therapeutics Inc. (DNLI) insider trading activity

Nancy Thornberry is Director of Denali Therapeutics Inc.. Currently has a direct ownership of 24,717 shares of DNLI, which is worth approximately $355,924. The most recent transaction as insider was on Jun 03, 2025, when has been sold 6,037 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 24.7K

32.32% 3M change

32.32% 12M change

Total Value Held $355,924

Nancy Thornberry Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 03 2025	BUY Grant, award, or other acquisition	-	6,037 Added 19.63%	24,717 Common Stock
May 31 2024	BUY Grant, award, or other acquisition	-	5,967 Added 24.21%	18,680 Common Stock
Jun 01 2023	BUY Grant, award, or other acquisition	-	4,216 Added 24.9%	12,713 Common Stock
Jun 02 2022	BUY Grant, award, or other acquisition	-	5,986 Added 41.33%	8,497 Common Stock
Jan 08 2022	BUY Grant, award, or other acquisition	-	627 Added 19.98%	2,511 Common Stock

Also insider at

SDGR

Schrodinger, Inc. Healthcare

Director

VRTX

VERTEX PHARMACEUTICALS INC Healthcare

Director